COSCIENS Biopharma Inc. Selling Expense
COSCIENS Biopharma Inc. (CSCIF) reported Selling Expense of $217.00 thousand for the 3-month period ending 2022-09-30, per its 6-K filed 2022-11-03.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:SellingExpense · last filed 2022-11-03
- COSCIENS Biopharma Inc. selling expense for the quarter ending 2022-09-30 was $217.00K, a 39.72% decline year-over-year.
- COSCIENS Biopharma Inc. selling expense for the quarter ending 2022-06-30 was $302.00K, a 5.03% decline year-over-year.
- COSCIENS Biopharma Inc. selling expense for the quarter ending 2022-03-31 was $303.00K, a 23.17% increase year-over-year.
- COSCIENS Biopharma Inc. selling expense for the quarter ending 2021-12-31 was $427.00K, a 5.69% increase year-over-year.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $217.00K 6-K · filed 2022-11-03 | $519.00K derived: sum of 2 quarters · filed 2022-11-03 | $822.00K 6-K · filed 2022-11-03 | $1.25M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $302.00K 6-K/A · filed 2022-08-04 | $605.00K 6-K/A · filed 2022-08-04 | $1.03M derived: sum of 3 quarters · filed 2022-08-04 | $1.39M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $303.00K 6-K · filed 2022-05-11 | $730.00K derived: sum of 2 quarters · filed 2022-05-11 | $1.09M derived: sum of 3 quarters · filed 2022-11-03 | $1.41M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $427.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | $787.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.10M derived: sum of 3 quarters · filed 2022-11-03 | $1.35M 20-F · filed 2022-03-29 |
| 2021-09-30 | $360.00K 6-K · filed 2022-11-03 | $678.00K derived: sum of 2 quarters · filed 2022-11-03 | $924.00K 6-K · filed 2022-11-03 | $1.33M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $318.00K 6-K/A · filed 2022-08-04 | $564.00K 6-K/A · filed 2022-08-04 | $968.00K derived: sum of 3 quarters · filed 2022-08-04 | $1.25M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $246.00K 6-K · filed 2022-05-11 | $650.00K derived: sum of 2 quarters · filed 2022-05-11 | $933.00K derived: sum of 3 quarters · filed 2022-05-11 | $1.13M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $404.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | $687.00K derived: sum of 2 quarters · filed 2022-03-29 | $886.00K derived: sum of 3 quarters · filed 2022-03-29 | $1.13M 20-F · filed 2022-03-29 |
| 2020-09-30 | $283.00K 6-K · filed 2021-11-04 | $482.00K derived: sum of 2 quarters · filed 2021-11-04 | $730.00K 6-K · filed 2021-11-04 | $768.00K derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-06-30 | $199.00K 6-K · filed 2021-08-05 | $447.00K 6-K · filed 2021-08-05 | $485.00K derived: sum of 3 quarters · filed 2022-03-29 | $862.00K derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-03-31 | $248.00K 6-K · filed 2021-05-05 | $286.00K derived: sum of 2 quarters · filed 2022-03-29 | $663.00K derived: sum of 3 quarters · filed 2022-03-29 | $1.16M derived: sum of 4 quarters · filed 2022-03-29 |
| 2019-12-31 | $38.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | $415.00K derived: sum of 2 quarters · filed 2022-03-29 | $910.00K derived: sum of 3 quarters · filed 2022-03-29 | $1.21M 20-F · filed 2022-03-29 |
| 2019-09-30 | $377.00K 6-K · filed 2020-11-05 | $872.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.18M 6-K · filed 2020-11-05 | $1.76M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $495.00K 6-K · filed 2020-08-06 | $799.00K 6-K · filed 2020-08-06 | $1.39M derived: sum of 3 quarters · filed 2020-08-06 | $1.77M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $304.00K 6-K/A · filed 2020-05-11 | $892.00K derived: sum of 2 quarters · filed 2020-05-11 | $1.27M derived: sum of 3 quarters · filed 2020-05-11 | $1.77M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $588.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | $971.00K derived: sum of 2 quarters · filed 2020-03-31 | $1.47M derived: sum of 3 quarters · filed 2020-03-31 | $3.11M 20-F · filed 2020-03-31 |
| 2018-09-30 | $383.00K 6-K · filed 2019-11-07 | $880.00K derived: sum of 2 quarters · filed 2019-11-07 | $2.52M 6-K · filed 2019-11-07 | |
| 2018-06-30 | $497.00K 6-K · filed 2019-08-13 | $2.14M 6-K · filed 2019-08-13 | ||
| 2017-12-31 | $5.09M 20-F · filed 2020-03-31 | |||
| 2016-12-31 | $6.75M 20-F · filed 2019-04-01 | |||
| 2015-12-31 | $6.89M 20-F · filed 2018-03-28 |